Haemonetics Corporation (HAE)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.87 (+1.08%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Haemonetics Corporation (HAE)
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Key Insights

Critical company metrics and information
  • Share Price

    $81.19
  • Market Cap

    $4.08 Billion
  • Total Outstanding Shares

    50.22 Million Shares
  • Total Employees

    3,657
  • Dividend

    No dividend
  • IPO Date

    May 9, 1991
  • SIC Description

    Surgical & Medical Instruments & Apparatus
  • Homepage

    https://www.haemonetics.com

Historical Stock Splits

If you bought 1 share of HAE before December 3, 2012, you'd have 2 shares today.
Execution DateSplit Amount
December 3, 20122-for-1

Cash Flow Statement

September 29, 2023 to September 28, 2024
MetricValue
Net Cash Flow$-51.72 Million
Net Cash Flow From Financing Activities$304.81 Million
Net Cash Flow, Continuing$-54.80 Million
Net Cash Flow From Investing Activities$-444.56 Million
Exchange Gains/Losses$3.08 Million
Net Cash Flow From Operating Activities, Continuing$84.94 Million
Net Cash Flow From Financing Activities, Continuing$304.81 Million
Net Cash Flow From Investing Activities, Continuing$-444.56 Million
Net Cash Flow From Operating Activities$84.94 Million

Income Statement

September 29, 2023 to September 28, 2024
MetricValue
Operating Income/Loss$167.37 Million
Basic Average Shares$101.72 Million
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Net Income/Loss Available To Common Stockholders, Basic$123.81 Million
Preferred Stock Dividends And Other Adjustments$0.00
Income Tax Expense/Benefit, Deferred$-15.16 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Benefits Costs and Expenses$1.20 Billion
Costs And Expenses$1.20 Billion
Net Income/Loss Attributable To Parent$123.81 Million
Income/Loss From Continuing Operations After Tax$123.81 Million
Diluted Average Shares$102.85 Million
Gross Profit$716.13 Million
Cost Of Revenue$645.09 Million
Income Tax Expense/Benefit$35.05 Million
Basic Earnings Per Share$2.44
Net Income/Loss$123.81 Million
Selling, General, and Administrative Expenses$448.59 Million
Research and Development$60.10 Million
Diluted Earnings Per Share$2.41
Operating Expenses$548.76 Million
Revenues$1.36 Billion
Income/Loss From Continuing Operations Before Tax$158.86 Million
Depreciation and Amortization$109.52 Million

Balance Sheet

September 29, 2023 to September 28, 2024
MetricValue
Other Current Assets$573.80 Million
Current Assets$955.90 Million
Liabilities$1.65 Billion
Inventory$382.11 Million
Intangible Assets$487.84 Million
Liabilities And Equity$2.53 Billion
Other Current Liabilities$155.40 Million
Assets$2.53 Billion
Equity Attributable To Noncontrolling Interest$0.00
Noncurrent Assets$1.57 Billion
Equity$878.85 Million
Accounts Payable$69.24 Million
Other Non-current Assets$781.01 Million
Wages$49.30 Million
Equity Attributable To Parent$878.85 Million
Fixed Assets$300.48 Million
Current Liabilities$273.95 Million
Noncurrent Liabilities$1.37 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Related Companies

View additional S&P 500 companies similar to Haemonetics Corporation (HAE)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.